Pharmaceutical Preparations
| Institution | Shares | Value | Ownership % | Change | Filing Date |
|---|---|---|---|---|---|
| VANGUARD CAPITAL MANAGEMENT LLC | 1.04M | $3.0M | 3.12% | +71.2K | 2026-06-30 |
| Opaleye Management Inc. | 890.0K | $2.0M | 2.68% | -152.0K | 2026-06-30 |
| MACKENZIE FINANCIAL CORP | 555.7K | $1.0M | 1.67% | -- | 2026-06-30 |
| GSA CAPITAL PARTNERS LLP | 458.5K | $1.0M | 1.38% | +204.3K | 2026-06-30 |
| SHIKIAR ASSET MANAGEMENT INC | 305.5K | -- | 0.92% | -- | 2026-06-30 |
| GEODE CAPITAL MANAGEMENT, LLC | 300.5K | -- | 0.90% | +10.3K | 2026-06-30 |
| BlackRock, Inc. | 224.8K | -- | 0.68% | +27.7K | 2026-06-30 |
| TWO SIGMA INVESTMENTS, LP | 213.8K | -- | 0.64% | -- | 2026-06-30 |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 177.4K | -- | 0.53% | -5.0K | 2026-06-30 |
| VANGUARD FIDUCIARY TRUST CO | 166.4K | -- | 0.50% | +23.8K | 2026-06-30 |
